Abstract: (1,4-Diaryl-purazol-3-yl)-acetic acids of the formula ##STR1## wherein Ar and Ar', which can be the same or different, represents a phenyl group optionally substituted with 1 or 3 halogen atoms, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy groups, are prepared by reacting .beta.-styryl amines with compounds of formula ClCO-CH.sub.2 -A (wherein A represents a CN, COOR or CONR.sup.1 R.sup.2 group, R being an alkyl, benzyl or benzohydryl group and R.sup.1 and R.sup.2 being H or an alkyl, benzyl or benzohydryl group).
Abstract: Pharmaceutical compositions having vasodilating and antianoxic activities containing an ubiquinone or Coenzyme Q.sub.10 and a vasodilating compound selected from the groups of ergotamine, Rauwolfia, vincamine alkaloids, calcium antagonists, .beta.-blockers, papaverine, Ginkgo biloba, xanthine derivatives, ACE inhibitors, cyclospasmol.
Abstract: Pharmaceutical compositions having vasculoprotecting activity, containing an ubiquinone compound together with one or more compounds of flavanoid, heparinoid, terpenic or glycosidic structure, such as escin, troxerutin, asiaticoside, heparin, delphinidin, tribenoside.
Abstract: The invention relates to novel pharmaceutical compositions containing ubiquinone, particularly Coenzyme Q.sub.10, and mixtures of phospholipids having organic or vegetal origin, in weight-ratios ranging from 1/1 to 1/100,000, together with pharmaceutically acceptable excipients.The pharmaceutical compositions of the invention are useful in the treatment of pathological conditions related to insufficient cerebral perfusion, atherosclerosis or enzymatic impairments involving cerebral metabolic deficiencies, and generally in conditions deriving from cerebral and tissular postanoxy.Said pharmaceutical composition allows a better absorption of Coenzyme Q.sub.10.
Abstract: This invention relates to compounds having the general formula: ##STR1## in which R.sub.1 is a hydrogen atom or a lower alkyl radical and n is zero or an integer from 1 to 4, and their salts with therapeutically acceptable organic or inorganic bases.Said compounds possess, in particular, choleretic, antiatherosclerotic, hypocholesterolemic and antiphlogistic activities.
Abstract: This invention relates to p-aminomethyl-benzene-sulfonamide derivatives having the formula: ##STR1## IN WHICH M is an ion of a metal atom selected from silver, zinc, aluminum, copper and cerium, and n is an integer from 1 to 4.Said compounds have typically an anti-bacterial activity, and also a healing and protective effect on skin burns.